Please login to the form below

Not currently logged in
Email:
Password:

Evenity

This page shows the latest Evenity news and features for those working in and with pharma, biotech and healthcare.

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal

Initially received a negative opinion of the drug. The EMA’s main advisory committee has changed its position on UCB and Amgen’s application for their severe osteoporosis drug Evenity, recommending ... Now, it has backed Evenity – an

Latest news

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics